Literature DB >> 1950703

Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia.

G Q Daley1, Y Ben-Neriah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1950703     DOI： 10.1016/s0065-230x(08)60998-7

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  11 in total

1.  p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues.

Authors:  R Dikstein; R Agami; D Heffetz; Y Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

Review 2.  The C2 domain calcium-binding motif: structural and functional diversity.

Authors:  E A Nalefski; J J Falke
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

3.  Constitutive association of BRCA1 and c-Abl and its ATM-dependent disruption after irradiation.

Authors:  Nicolas Foray; Didier Marot; Voahangy Randrianarison; Nicole Dalla Venezia; Didier Picard; Michel Perricaudet; Vincent Favaudon; Penny Jeggo
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Protein tyrosine phosphatase PTP1B suppresses p210 bcr-abl-induced transformation of rat-1 fibroblasts and promotes differentiation of K562 cells.

Authors:  K R LaMontagne; G Hannon; N K Tonks
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

5.  Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line.

Authors:  G Q Daley; R A Van Etten; P K Jackson; A Bernards; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

6.  Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.

Authors:  M Zion; D Ben-Yehuda; A Avraham; O Cohen; M Wetzler; D Melloul; Y Ben-Neriah
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

7.  The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.

Authors:  M W Renshaw; J R McWhirter; J Y Wang
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

8.  c-Abl kinase regulates the protein binding activity of c-Crk.

Authors:  S M Feller; B Knudsen; H Hanafusa
Journal:  EMBO J       Date:  1994-05-15       Impact factor: 11.598

9.  Crosstalk between BCR/ABL oncoprotein and CXCR4 signaling through a Src family kinase in human leukemia cells.

Authors:  Andrzej Ptasznik; Elzbieta Urbanowska; Suneetha Chinta; Melinda A Costa; Benjamin A Katz; Marisha A Stanislaus; Gokhan Demir; Diana Linnekin; Zhixing K Pan; Alan M Gewirtz
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

10.  Ponatinib is a pan-BCR-ABL kinase inhibitor: MD simulations and SIE study.

Authors:  Karunakar Tanneeru; Lalitha Guruprasad
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.